Statement by India at the 142nd Session of the Executive Board (EB) of the World Health Organization (22nd to 27th January 2018) on Agenda item 5.1: Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits, delivered by Sh. Lav Agarwal, Joint Secretary, Ministry of Health and Family Welfare. [WHO HQ, Geneva, 26th January 2018] Statement by India at the 142nd Session of the Executive Board (EB) of the World Health Organization..
  • Home > Health > Statement by India at the 142nd Session of the Executive Board (EB) of the World Health Organization (22nd to 27th January 2018) on Agenda item 5.1: Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits, delivered by Sh. Lav Agarwal, Joint Secretary, Ministry of Health and Family Welfare. [WHO HQ, Geneva, 26th January 2018]

Statement by India at the 142nd Session of the Executive Board (EB) of the World Health Organization (22nd to 27th January 2018) on Agenda item 5.1: Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits, delivered by Sh. Lav Agarwal, Joint Secretary, Ministry of Health and Family Welfare. [WHO HQ, Geneva, 26th January 2018]

 Mr. Chair:

India supports the proposed decision that major component of resources should be used for pandemic preparedness.

2. In order to ensure the sustainability of PIP Framework, it should cater to the interest of Member States & all major stakeholders and the delivery of results needs to be regularly monitored, measured and communicated.

3. India reiterates that WHO and State Parties should ensure that sharing of samples and sequence data is balanced with benefit-sharing on an equal footing.

Mr. Chair, 

4. A transparent process should be followed to evaluate the countries for continuation for funding. Countries like India which have high disease burden should get priority in receiving influenza vaccines.

5. India proposes that there is a greater need for technology transfer and capacity building for manufacturing of influenza vaccine in developing countries. Collaborations between countries should be strengthened for efficient utilization of laboratory services and other capacities.

6. India is fully committed to support WHO in its efforts.

Thank you.